UK markets closed
NIKKEI 225
38,073.98 -128.39 (-0.34%) HANG SENG
18,537.81 +223.95 (+1.22%) CRUDE OIL
79.56 +0.57 (+0.72%) GOLD FUTURES
2,344.70 +22.40 (+0.96%) DOW
39,381.21 +324.82 (+0.83%) Bitcoin GBP
49,783.71 +44.16 (+0.09%)
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 03:45PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 78.73M |
| Enterprise value | 73.98M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 13.77 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.87 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.05 |
| 52-week change 3 | -64.39% |
| S&P500 52-week change 3 | 25.59% |
| 52-week high 3 | 8.6100 |
| 52-week low 3 | 2.0800 |
| 50-day moving average 3 | 3.3254 |
| 200-day moving average 3 | 4.1683 |
Share statistics
| Avg vol (3-month) 3 | 254.38k |
| Avg vol (10-day) 3 | 135.77k |
| Shares outstanding 5 | 27.92M |
| Implied shares outstanding 6 | 27.92M |
| Float 8 | 21.14M |
| % held by insiders 1 | 17.71% |
| % held by institutions 1 | 18.07% |
| Shares short (15 Apr 2024) 4 | 1.23M |
| Short ratio (15 Apr 2024) 4 | 3.37 |
| Short % of float (15 Apr 2024) 4 | 6.63% |
| Short % of shares outstanding (15 Apr 2024) 4 | 4.42% |
| Shares short (prior month 15 Mar 2024) 4 | 650.65k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -115.85% |
| Return on equity (ttm) | -556.38% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -39.26M |
| Diluted EPS (ttm) | -1.6500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 23.37M |
| Total cash per share (mrq) | 0.84 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.38 |
| Book value per share (mrq) | 0.20 |
Cash flow statement
| Operating cash flow (ttm) | -28.32M |
| Levered free cash flow (ttm) | -13.99M |
© 2024 Yahoo. All rights reserved.